 JACKSON CENTER, PA ACCESSWIRE January 14, 2021 Halberd Corp. OTC PINK:HALB announced the filing of a provisional patent application on a proprietary combination of nutritional supplements melatonin, zinc and Vitamin D combined with low dose Naltrexone designed to reduce the severity of Covid-19 symptoms. This proprietary combination of supplements is based on numerous peer-reviewed publications 1, 2, 3, 4, 5, 6, 7 from major medical organizations indicating that each of the ingredients contributes to reduced Covid-19 symptomology. 